Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Phillip Capital
Equibles does not estimate personal net worth.
Surin Narayan Patra is recorded as Analyst at Phillip Capital. Surin Narayan Patra has spoken on 3 earnings calls across 3 companies, most recently for Thyrocare Technologies Limited on July 23, 2026. Those appearances were for Thyrocare Technologies Limited, Cipla Limited and Vinati Organics Limited. The companies whose calls Surin Narayan Patra spoke on are classified in the Healthcare and Basic Materials sectors.
“See, congratulations for the great set of numbers. So, one thing that I just observed that, okay, there is a 24% kind of growth that we have reported on the company, for the company as a whole, and the franchisee growth itself, 23%.”
“We have indicated that there was some volume impact as well as price-related impact that we would have seen in the current fourth quarter.”
Phillip Capital
Analyst
Transcript header (unverified)
Cipla Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Thyrocare Technologies Limited
Diagnostics & Research · Healthcare
Vinati Organics Limited
Specialty Chemicals · Basic Materials
Earnings Call
Cipla Limited
Thyrocare Technologies Limited Q1 FY27 Earnings Conference Call
Thyrocare Technologies Limited
Earnings Call for the Quarter Ended March 31, 2026
Vinati Organics Limited